When the U.S. deeming regulations come into effect on 8th of August, the distribution of free e-liquid samples will be prohibited in the U.S. The U.S. Food and Drug Administration (FDA) justifies this ban as necessary for the protection of the public health but retailers believe it will undermine their profits without having a noticeable public health benefit. What challenges follow?
Written by Aidan Semmens || 29th July 2016 || Regulatory reports , Topic regulatory reports | Health and science | Marketing and Retailing | Policy and Politics | Regulation and Legislation | Arkansas Georgia US Iowa Kentucky Massachusetts New Hampshire New Mexico North America Oklahoma Rhode Island South Dakota Tennessee United States